Parallax Volatility Advisers, L.P. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 874 filers reported holding NOVARTIS A G in Q3 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,546,500
-14.2%
25,000
-15.0%
0.01%0.0%
Q2 2023$2,966,754
-77.7%
29,400
-79.7%
0.01%
-77.8%
Q1 2023$13,330,800
-2.0%
144,900
-3.4%
0.03%
+28.6%
Q4 2022$13,608,000
-32.2%
150,000
-43.2%
0.02%
-32.3%
Q3 2022$20,067,000
-14.9%
264,000
-2.0%
0.03%
+40.9%
Q4 2021$23,572,000
+433.4%
269,497
+398.7%
0.02%
+633.3%
Q3 2021$4,419,000
+1599.6%
54,041
+1860.1%
0.00%
Q4 2020$260,000
-15.3%
2,757
-21.7%
0.00%
Q3 2020$307,000
+13.3%
3,523
+13.1%
0.00%
Q2 2020$271,000
-79.1%
3,116
-80.2%
0.00%
-100.0%
Q1 2020$1,294,000
-89.4%
15,700
-87.8%
0.00%
-85.7%
Q4 2019$12,152,000
+1.3%
128,338
-7.0%
0.01%0.0%
Q3 2019$11,994,000
-55.6%
137,992
-53.4%
0.01%
-51.7%
Q2 2019$27,022,000
+31.6%
295,923
+38.5%
0.03%
+20.8%
Q1 2019$20,537,000
+22222.8%
213,615
+19864.0%
0.02%
Q4 2018$92,000
-99.3%
1,070
-99.3%
0.00%
-100.0%
Q3 2018$13,143,000
+484.1%
152,553
+469.2%
0.02%
+433.3%
Q4 2017$2,250,000
+498.4%
26,800
+495.6%
0.00%
+200.0%
Q2 2017$376,000
-25.2%
4,500
-26.2%
0.00%0.0%
Q2 2016$503,000
-95.0%
6,100
-95.3%
0.00%
-98.1%
Q3 2013$10,011,000
-31.6%
130,500
-37.0%
0.05%
-22.1%
Q2 2013$14,637,000207,0000.07%
Other shareholders
NOVARTIS A G shareholders Q3 2016
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders